Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Camm

Showing results (31-40 of 662) with videos related to

Pageof 67
Sort By:
Cardiovascular Research|July 27, 2019
RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation proceduresA John Camm
JACC. Advances|June 28, 2024
If a Thing Is Worth Doing, it Is Worth Doing WellA John Camm
International Journal of Cardiology|April 3, 2017
Hopes and disappointments with antiarrhythmic drugsA John Camm
Heart Rhythm|October 29, 2005
Clinical trial design to evaluate the effects of drugs on cardiac repolarization: current state of the artA John Camm
Thrombosis and Haemostasis|March 23, 2018
The Evolution of Antithrombotic Care in Cardiovascular PatientsA John Camm
Journal of Cardiovascular Electrophysiology|September 3, 2003
Translation of clinical trials into clinical practice: use of results in formulating guidelinesA John Camm
Fundamental & Clinical Pharmacology|May 29, 2002
The design and conduct of human studies to detect and quantify QT interval prolongation induced by new chemical entitiesA John Camm
Nature Clinical Practice. Cardiovascular Medicine|July 1, 2006
Ablation for atrial fibrillationA John Camm
Clinical Cardiology|January 17, 2012
Atrial fibrillation and riskA John Camm
Revista Espanola De Cardiologia|December 15, 2010
Quality of life in patients with atrial fibrillationA John Camm
Pageof 67

Showing results (31-40 of 662) with videos related to

Sort By:
Pageof 67
Cardiovascular Research|July 27, 2019
RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation proceduresA John Camm
JACC. Advances|June 28, 2024
If a Thing Is Worth Doing, it Is Worth Doing WellA John Camm
International Journal of Cardiology|April 3, 2017
Hopes and disappointments with antiarrhythmic drugsA John Camm
Heart Rhythm|October 29, 2005
Clinical trial design to evaluate the effects of drugs on cardiac repolarization: current state of the artA John Camm
Thrombosis and Haemostasis|March 23, 2018
The Evolution of Antithrombotic Care in Cardiovascular PatientsA John Camm
Journal of Cardiovascular Electrophysiology|September 3, 2003
Translation of clinical trials into clinical practice: use of results in formulating guidelinesA John Camm
Fundamental & Clinical Pharmacology|May 29, 2002
The design and conduct of human studies to detect and quantify QT interval prolongation induced by new chemical entitiesA John Camm
Nature Clinical Practice. Cardiovascular Medicine|July 1, 2006
Ablation for atrial fibrillationA John Camm
Clinical Cardiology|January 17, 2012
Atrial fibrillation and riskA John Camm
Revista Espanola De Cardiologia|December 15, 2010
Quality of life in patients with atrial fibrillationA John Camm
Pageof 67